Thoma Bravo Invests in Bluesight to Support Bluesight's Acquisition of Medacist
July 17, 2023
Thoma Bravo made a strategic growth investment in Bluesight to support Bluesight's acquisition of Medacist, combining two medication-management and drug-diversion analytics businesses into a single hospital pharmacy software platform. The combined company will expand Bluesight's medication intelligence capabilities and serve more than 2,000 hospitals across North America; committed financing was led by Monroe Capital and existing investor New Leaf Ventures remains invested. Financial terms were not disclosed.
- Buyers
- Thoma Bravo, Bluesight, Monroe Capital LLC
- Targets
- Medacist
- Platforms
- Bluesight
- Industry
- Healthcare Services
- Location
- Connecticut, United States
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
Bluesight Acquires Protenus to Expand Healthcare Compliance Capabilities
January 9, 2025
Healthcare Services
Bluesight, a provider of inventory management, procurement, and compliance solutions for hospitals, has acquired Protenus, a Baltimore-based healthcare compliance analytics platform. The acquisition expands Bluesight's drug diversion and patient privacy monitoring capabilities, combining AI-driven compliance analytics with Bluesight's hospital and pharmacy operations intelligence.
-
Bluesight Acquires Sectyr
October 17, 2024
Healthcare Services
Bluesight, a provider of Medication Intelligence solutions, has acquired Sectyr, a cloud-based compliance and audit management platform focused on 340B program management. The acquisition adds 340B audit and compliance capabilities to Bluesight’s product suite to improve pharmacy compliance, audit readiness, and operational visibility for hospitals and health systems.
-
Thoma Bravo Makes Strategic Growth Investment in BlueMatrix
December 14, 2023
Cloud & SaaS
Thoma Bravo has completed a strategic growth investment in BlueMatrix, a cloud-based content creation and distribution platform for investment research providers. The investment (debt financing provided by Golub Capital) will support BlueMatrix’s global growth and continued product innovation while founder and CEO Patricia Horotan remains in her leadership role with a significant ownership stake.
-
Thoma Bravo Makes Strategic Investment in Grayshift
June 21, 2022
Cybersecurity
Thoma Bravo has completed a strategic growth investment in Grayshift, a U.S.-based provider of mobile device digital forensics solutions. The capital will support Grayshift’s product innovation, international expansion, and potential strategic acquisitions; existing investors PeakEquity Partners and C&B Capital will remain shareholders.
-
Thoma Bravo Acquires Darktrace
October 1, 2024
Cybersecurity
Thoma Bravo has completed its all-cash acquisition of Darktrace in a transaction valued at approximately $5.3 billion, following a recommended Scheme of Arrangement. The private equity firm intends to partner with Darktrace's management to scale the cybersecurity AI platform, invest in R&D and expand its global reach.
-
Thoma Bravo Acquires Medallia for $6.4B
October 29, 2021
Cloud & SaaS
Thoma Bravo completed its all-cash acquisition of Medallia, a San Francisco–based leader in customer and employee experience software, in a transaction valued at approximately $6.4 billion. Medallia shareholders received $34.00 per share; Thoma Bravo said it will leverage its software operating expertise and the company’s SaaS and AI capabilities to expand Medallia’s customer reach and accelerate product innovation.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.